buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet
- RxCUI
- 351266
- RxNorm name
- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet
- Display name
- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet
- Full name
- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:51
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BUPRENORPHINE AND NALOXONE | BUPRENORPHINE AND NALOXONE | Ascend Laboratories, LLC | 2e807ed0-6df3-47b5-b7ee-b421c5bf0aa7 | 2026-06-29 | Warnings, Adverse reactions | 351266 |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Bryant Ranch Prepack | 4b1df792-f56c-4c0c-92b0-a887f4225567 | 2026-06-16 | Warnings, Adverse reactions | 351266 |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Bryant Ranch Prepack | fc2755a5-3292-4b49-872d-e22c386a4e44 | 2026-06-11 | Warnings, Adverse reactions | 351266 |
| buprenorphine hydrochloride and naloxone hydrochloride dihydrate | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE | REMEDYREPACK INC. | 43027750-d218-49e5-867f-c941736d2056 | 2026-06-10 | Warnings, Adverse reactions | 351266 |
| Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE | SpecGx LLC | 62abde41-46cb-4e90-a798-23d6531bf9aa | 2026-06-10 | Warnings, Adverse reactions | 351266 |
| Buprenorphine HCl and Naloxone HCl | BUPRENORPHINE AND NALOXONE | Bryant Ranch Prepack | e82e2d74-33a8-4894-82f6-788fc0f9feec | 2026-06-08 | Warnings, Adverse reactions | 351266 |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Bryant Ranch Prepack | dd6e4fc9-a6f7-458a-b075-d736ce8b7172 | 2026-06-03 | Warnings, Adverse reactions | 351266 |
| buprenorphine hydrochloride and naloxone hydrochloride dihydrate | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE | Bryant Ranch Prepack | a0f8c28c-ed9a-4a26-91a3-b996c117ac2c | 2026-05-14 | Warnings, Adverse reactions | 351266 |
| buprenorphine hydrochloride and naloxone hydrochloride dihydrate | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE | Bryant Ranch Prepack | d25b1a73-9794-4e86-82eb-dee3f159a214 | 2026-05-13 | Warnings, Adverse reactions | 351266 |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Rhodes Pharmaceuticals LLC | 794724a6-0fba-bc8d-ecdb-9e3be8ea2191 | 2026-05-01 | Warnings, Adverse reactions | 351266 |
| buprenorphine hydrochloride and naloxone hydrochloride dihydrate | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE | Golden State Medical Supply, Inc. | 4f6e0056-b19d-0d0e-e063-6294a90a16e5 | 2026-04-24 | Warnings, Adverse reactions | 351266 |
| Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE | Unit Dose Solutions, Inc. | 4f979409-f9a2-d3a2-e063-6394a90accd0 | 2026-04-16 | Warnings, Adverse reactions | 351266 |
| Buprenorphine HCl and Naloxone HCl | BUPRENORPHINE AND NALOXONE | Bryant Ranch Prepack | 2aaad1a7-a0fd-4dd5-bb53-03afad8f10b9 | 2026-04-03 | Warnings, Adverse reactions | 351266 |
| buprenorphine hydrochloride and naloxone hydrochloride dihydrate | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE | Clinical Solutions Wholesale, LLC | 99a5b62f-bc08-44f4-abb8-300520d2162a | 2026-03-06 | Warnings, Adverse reactions | 351266 |
| BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE | Clinical Solutions Wholesale, LLC | 8f2b94dc-f42f-45d5-8274-9e748ec20ef0 | 2026-03-05 | Warnings, Adverse reactions | 351266 |
| buprenorphine hydrochloride and naloxone hydrochloride dihydrate | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE | Major Pharmaceuticals | c5fbec69-e7de-44a8-b9fa-0378ae61a9fe | 2026-03-03 | Warnings, Adverse reactions | 351266 |
| Buprenorphine and Naloxone | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma | d5b011ef-f1be-47f2-8f8b-07553f36193c | 2026-02-19 | Warnings, Adverse reactions | 351266 |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Sun Pharmaceutical Industries, Inc. | 91b68606-05de-4586-ae31-07e8cc9160cf | 2026-02-10 | Warnings, Adverse reactions | 351266 |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Actavis Pharma, Inc. | 6cccf229-9611-4b6f-8f1b-acc8ff1ed3f8 | 2026-02-06 | Warnings, Adverse reactions | 351266 |
| Buprenorphine HCl and Naloxone HCl | BUPRENORPHINE AND NALOXONE | Amneal Pharmaceuticals LLC | 17b63f10-c9df-44be-80fa-6f1c305583b8 | 2026-02-02 | Warnings, Adverse reactions | 351266 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2aaad1a7-a0fd-4dd5-bb53-03afad8f10b9 | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 1007 | These highlights do not include all the information needed to use B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE AND NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20260403 |
| 2aaad1a7-a0fd-4dd5-bb53-03afad8f10b9 | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 1007 | These highlights do not include all the information needed to use B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE AND NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20260403 |
| 2aaad1a7-a0fd-4dd5-bb53-03afad8f10b9 | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 1007 | These highlights do not include all the information needed to use B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE AND NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20260403 |
| a0f8c28c-ed9a-4a26-91a3-b996c117ac2c | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 106 | These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260514 |
| a0f8c28c-ed9a-4a26-91a3-b996c117ac2c | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 106 | These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260514 |
| a0f8c28c-ed9a-4a26-91a3-b996c117ac2c | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 106 | These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260514 |
| dd6e4fc9-a6f7-458a-b075-d736ce8b7172 | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 105 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | 20240814 |
| dd6e4fc9-a6f7-458a-b075-d736ce8b7172 | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 105 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | 20240814 |
| dd6e4fc9-a6f7-458a-b075-d736ce8b7172 | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 105 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | 20240814 |
| 4b1df792-f56c-4c0c-92b0-a887f4225567 | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 104 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | 20260403 |
| 4b1df792-f56c-4c0c-92b0-a887f4225567 | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 104 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | 20260403 |
| 4b1df792-f56c-4c0c-92b0-a887f4225567 | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 104 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | 20260403 |
| 17b63f10-c9df-44be-80fa-6f1c305583b8 | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 55 | These highlights do not include all the information needed to use B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE AND NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260202 |
| 17b63f10-c9df-44be-80fa-6f1c305583b8 | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 55 | These highlights do not include all the information needed to use B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE AND NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260202 |
| 17b63f10-c9df-44be-80fa-6f1c305583b8 | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 55 | These highlights do not include all the information needed to use B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE AND NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260202 |
| 6cccf229-9611-4b6f-8f1b-acc8ff1ed3f8 | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 49 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE s ublingual t ablets, CIII Initial U.S. Approval: 2002 | 20260206 |
| 6cccf229-9611-4b6f-8f1b-acc8ff1ed3f8 | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 49 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE s ublingual t ablets, CIII Initial U.S. Approval: 2002 | 20260206 |
| 6cccf229-9611-4b6f-8f1b-acc8ff1ed3f8 | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 49 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE s ublingual t ablets, CIII Initial U.S. Approval: 2002 | 20260206 |
| 91b68606-05de-4586-ae31-07e8cc9160cf | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 33 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260210 |
| 91b68606-05de-4586-ae31-07e8cc9160cf | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 33 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260210 |
| 91b68606-05de-4586-ae31-07e8cc9160cf | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 33 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260210 |
| 62abde41-46cb-4e90-a798-23d6531bf9aa | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 33 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS . BUPRENORPHINE AND NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20251224 |
| 62abde41-46cb-4e90-a798-23d6531bf9aa | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 33 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS . BUPRENORPHINE AND NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20251224 |
| 62abde41-46cb-4e90-a798-23d6531bf9aa | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 33 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS . BUPRENORPHINE AND NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20251224 |
| 14eaa94a-cc8a-4e1e-8cfb-5c976c96c606 | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 32 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20260128 |
| 14eaa94a-cc8a-4e1e-8cfb-5c976c96c606 | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 32 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20260128 |
| 14eaa94a-cc8a-4e1e-8cfb-5c976c96c606 | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 32 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20260128 |
| 713db2c6-0544-4633-b874-cfbeaf93db89 | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 31 | These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260123 |
| 713db2c6-0544-4633-b874-cfbeaf93db89 | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 31 | These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260123 |
| 713db2c6-0544-4633-b874-cfbeaf93db89 | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 31 | These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260123 |
| b955054b-b37d-4079-4fed-5939b763ecb4 | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 11 | Buprenorphine and Naloxone Sublingual Tablets CIII Rx Only These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE AND NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260108 |
| b955054b-b37d-4079-4fed-5939b763ecb4 | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 11 | Buprenorphine and Naloxone Sublingual Tablets CIII Rx Only These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE AND NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260108 |
| b955054b-b37d-4079-4fed-5939b763ecb4 | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 11 | Buprenorphine and Naloxone Sublingual Tablets CIII Rx Only These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE AND NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260108 |
| 794724a6-0fba-bc8d-ecdb-9e3be8ea2191 | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 9 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | 20260501 |
| 794724a6-0fba-bc8d-ecdb-9e3be8ea2191 | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 9 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | 20260501 |
| 794724a6-0fba-bc8d-ecdb-9e3be8ea2191 | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 9 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | 20260501 |
| c5fbec69-e7de-44a8-b9fa-0378ae61a9fe | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 9 | These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260303 |
| c5fbec69-e7de-44a8-b9fa-0378ae61a9fe | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 9 | These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260303 |
| c5fbec69-e7de-44a8-b9fa-0378ae61a9fe | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 9 | These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260303 |
| 35d29e9b-9950-452a-a795-5a7514f0edfd | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 8 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20230503 |
| 35d29e9b-9950-452a-a795-5a7514f0edfd | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 8 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20230503 |
| 35d29e9b-9950-452a-a795-5a7514f0edfd | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 8 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20230503 |
| d5b011ef-f1be-47f2-8f8b-07553f36193c | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 7 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE AND NALOXONE Sublingual Tablets for sublingual administration CIII Initial U.S. Approval: 2002 | 20260219 |
| d5b011ef-f1be-47f2-8f8b-07553f36193c | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 7 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE AND NALOXONE Sublingual Tablets for sublingual administration CIII Initial U.S. Approval: 2002 | 20260219 |
| d5b011ef-f1be-47f2-8f8b-07553f36193c | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 7 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE AND NALOXONE Sublingual Tablets for sublingual administration CIII Initial U.S. Approval: 2002 | 20260219 |
| e82e2d74-33a8-4894-82f6-788fc0f9feec | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 7 | These highlights do not include all the information needed to use B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE AND NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20240520 |
| e82e2d74-33a8-4894-82f6-788fc0f9feec | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 7 | These highlights do not include all the information needed to use B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE AND NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20240520 |
| e82e2d74-33a8-4894-82f6-788fc0f9feec | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 7 | These highlights do not include all the information needed to use B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for B UPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE AND NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20240520 |
| d25b1a73-9794-4e86-82eb-dee3f159a214 | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 6 | These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260513 |
| d25b1a73-9794-4e86-82eb-dee3f159a214 | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 6 | These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260513 |
| d25b1a73-9794-4e86-82eb-dee3f159a214 | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 6 | These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260513 |
| b05b0087-c0ef-40be-9bf3-3933f6cd3492 | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 5 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | 20240820 |
| b05b0087-c0ef-40be-9bf3-3933f6cd3492 | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 5 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | 20240820 |
| b05b0087-c0ef-40be-9bf3-3933f6cd3492 | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 5 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE sublingual tablets, USP safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE sublingual tablets, USP. BUPRENORPHINE and NALOXONE sublingual tablets, USP, CIII Initial U.S. Approval: 2002 | 20240820 |
| fc2755a5-3292-4b49-872d-e22c386a4e44 | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 5 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20240517 |
| fc2755a5-3292-4b49-872d-e22c386a4e44 | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 5 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20240517 |
| fc2755a5-3292-4b49-872d-e22c386a4e44 | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 5 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20240517 |
| 43027750-d218-49e5-867f-c941736d2056 | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 3 | These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20251027 |
| 43027750-d218-49e5-867f-c941736d2056 | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 3 | These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20251027 |
| 43027750-d218-49e5-867f-c941736d2056 | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 3 | These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20251027 |
| 4f6e0056-b19d-0d0e-e063-6294a90a16e5 | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 2 | BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260424 |
| 4f6e0056-b19d-0d0e-e063-6294a90a16e5 | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 2 | BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260424 |
| 4f6e0056-b19d-0d0e-e063-6294a90a16e5 | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 2 | BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260424 |
| 99a5b62f-bc08-44f4-abb8-300520d2162a | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 2 | These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260306 |
| 99a5b62f-bc08-44f4-abb8-300520d2162a | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 2 | These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260306 |
| 99a5b62f-bc08-44f4-abb8-300520d2162a | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 2 | These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260306 |
| 273b79ac-2c62-4407-9cd1-2a2964ef13ba | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 2 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE AND NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20240109 |
| 273b79ac-2c62-4407-9cd1-2a2964ef13ba | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 2 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE AND NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20240109 |
| 273b79ac-2c62-4407-9cd1-2a2964ef13ba | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 2 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE AND NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20240109 |
| 4f979409-f9a2-d3a2-e063-6394a90accd0 | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 1 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS . BUPRENORPHINE AND NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20260416 |
| 4f979409-f9a2-d3a2-e063-6394a90accd0 | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 1 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS . BUPRENORPHINE AND NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20260416 |
| 4f979409-f9a2-d3a2-e063-6394a90accd0 | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 1 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS . BUPRENORPHINE AND NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20260416 |
| 8f2b94dc-f42f-45d5-8274-9e748ec20ef0 | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 1 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260305 |
| 8f2b94dc-f42f-45d5-8274-9e748ec20ef0 | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 1 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260305 |
| 8f2b94dc-f42f-45d5-8274-9e748ec20ef0 | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 1 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | 20260305 |
| 5ab2d4e4-3c8c-413a-b147-23eafbde313a | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 1 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20260128 |
| 5ab2d4e4-3c8c-413a-b147-23eafbde313a | buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet | PSN | 1 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20260128 |
| 5ab2d4e4-3c8c-413a-b147-23eafbde313a | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 1 | These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE sublingual tablets, CIII Initial U.S. Approval: 2002 | 20260128 |
| 97677ce7-9562-43d0-8b99-8d1f37c1e3c6 | buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet | SCD | 1 | 20100727 | |
| 97677ce7-9562-43d0-8b99-8d1f37c1e3c6 | buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet | SY | 1 | 20100727 |